WVE
Wave Life Sciences Ltd
3.80$
-4.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 64.3% | 7.5% | 17.4% | 11.0% | – | 78.5% | 23.6% | 25.2% | – | 13.1% | – | – | – | |
| 35.7% | 92.5% | 100.0% | 100.0% | – | 100.0% | 76.4% | 74.8% | 100.0% | 86.9% | 100.0% | 100.0% | 96.5% | |
| 64.3% | 117.3% | 266.8% | 205.1% | – | 53.3% | 442.7% | 499.7% | 603.0% | 306.3% | 124.0% | 2,257.6% | 302.0% | |
| 26.7% | 47.0% | 108.1% | 72.6% | – | 19.3% | 200.1% | 206.8% | 237.7% | 121.2% | 57.8% | 1,090.7% | 131.4% | |
| 26.7% | 156.8% | 374.8% | 277.7% | – | 72.6% | 619.2% | 681.3% | 840.7% | 414.3% | 181.8% | 3,348.3% | 429.9% | |
| 9.0% | -64.3% | -274.8% | -177.7% | – | 27.4% | -542.8% | -606.5% | -740.7% | -327.4% | -81.8% | -3,248.3% | -333.4% | |
| – | 9.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 16.1% | -55.9% | -251.7% | -167.2% | – | 34.9% | -510.9% | -580.2% | -707.8% | -308.4% | -68.2% | -3,052.6% | -309.7% | |
| 1.4% | 25.7% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 14.7% | -55.9% | -251.7% | -167.2% | – | 34.9% | -510.9% | -580.2% | -707.8% | -308.4% | -68.2% | -3,052.6% | -309.7% | |
| 18.5% | -48.4% | -234.3% | -156.2% | – | 37.5% | -487.3% | -554.9% | -678.5% | -295.3% | -62.2% | -3,134.7% | -302.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.